Close Menu

New guidelines for the diagnosis of Alzheimer's disease are to be released today by the National Institute on Aging and the Alzheimer's Association, reports The New York Times. The new definition breaks the disease down into three stages: when dementia has set in, when there are symptoms, but the person can still perform daily tasks, and when there are not yet symptoms, but changes are occurring in the person's brain. That early, symptom-free stage would be assessed through biomarkers.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

IBM security researchers warn of a phishing campaign targeted at organizations involved in the distribution of SARS-CoV-2 vaccines, the Verge reports.

The Illinois police have cut the number of DNA tests waiting to be run in about half, CBS Chicago reports.

A researcher accused of smuggling research materials out of the US has pleaded guilty to making false statements, according to the Associated Press.

In Science this week: gene expression signature linked to nonalcoholic fatty liver disease progression, and more.